Singapore markets close in 1 hour 5 minutes
Straits Times Index
3,300.39 +3.50 (+0.11%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,456.77 +249.64 (+1.37%) FTSE 100
8,191.34 +19.19 (+0.23%) Bitcoin USD
59,144.70 +1,505.80 (+2.61%) CMC Crypto 200
1,292.82 +15.84 (+1.24%)
Crinetics Pharmaceuticals, Inc. (CRNX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 45.05 |
| Open | 45.61 |
| Bid | 46.76 x 200 |
| Ask | 46.87 x 200 |
| Day's range | 44.84 - 46.96 |
| 52-week range | 15.76 - 49.58 |
| Volume | |
| Avg. volume | 814,470 |
| Market cap | 3.684B |
| Beta (5Y monthly) | 0.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Insider Sell: COO Jeff Knight Sells 32,359 Shares of Crinetics Pharmaceuticals Inc (CRNX)
Jeff Knight, the Chief Operating Officer of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX), has sold 32,359 shares of the company on March 22, 2024, according to a recent SEC filing.
- GuruFocus.com
Insider Sell: Chief Medical and Development Officer Dana Pizzuti Sells 15,089 Shares of ...
Chief Medical and Development Officer Dana Pizzuti of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) sold 15,089 shares of the company on March 20, 2024, according to a recent SEC filing.
- GuruFocus.com
Director Matthew Fust Sells 60,000 Shares of Crinetics Pharmaceuticals Inc (CRNX)
Director Matthew Fust has sold 60,000 shares of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) on March 20, 2024, according to a recent SEC Filing.
© 2024 Yahoo. All rights reserved.